BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
96.25
+0.25 (0.26%)
At close: Dec 5, 2025, 4:00 PM EST
97.09
+0.84 (0.87%)
After-hours: Dec 5, 2025, 7:17 PM EST
BioNTech SE Stock Forecast
Stock Price Forecast
According to 11 professional analysts, the 12-month price target for BioNTech SE stock ranges from a low of $110 to a high of $171.44. The average analyst price target of $137.4 forecasts a 42.75% increase in the stock price over the next year.
Price Target: $137.40 (+42.75%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BioNTech SE stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 8 | 7 | 5 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 18 | 18 | 18 | 15 | 14 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $136 → $140 | Strong Buy | Maintains | $136 → $140 | +45.45% | Nov 10, 2025 |
| UBS | UBS | Hold Maintains $115 → $117 | Hold | Maintains | $115 → $117 | +21.56% | Nov 6, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $121 → $120 | Hold | Maintains | $121 → $120 | +24.68% | Oct 23, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $133 → $131 | Buy | Maintains | $133 → $131 | +36.10% | Oct 10, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $116 → $121 | Hold | Maintains | $116 → $121 | +25.71% | Sep 22, 2025 |
Financial Forecast
Revenue This Year
2.82B
from 2.75B
Increased by 2.36%
Revenue Next Year
2.74B
from 2.82B
Decreased by -2.63%
EPS This Year
-3.25
from -2.77
EPS Next Year
-3.17
from -3.25
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.5B | 3.6B | ||||
| Avg | 2.8B | 2.7B | ||||
| Low | 2.6B | 1.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 28.4% | 29.2% | ||||
| Avg | 2.4% | -2.6% | ||||
| Low | -6.6% | -36.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.53 | 1.58 | ||||
| Avg | -3.25 | -3.17 | ||||
| Low | -5.46 | -8.54 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.